Table 2 |
||||||
|
Details of sample size, sex distribution, age and BMI for each leptin treatment group |
||||||
|
Leptin 20 ng/ml |
Leptin 100 ng/ml |
Leptin 500 ng/ml |
||||
|
|
|
|
||||
|
BMI <30 |
BMI >30 |
BMI <30 |
BMI >30 |
BMI <30 |
BMI >30 |
|
|
|
||||||
|
N |
5 (3 F, 2 M) |
5 (2 F, 3 M) |
8 (5 F, 3 M) |
11 (7 F, 4 M) |
8 (5 F, 3 M) |
9 (6 F, 3 M) |
|
Age (years) |
69.4 (4.5) |
67.8 (4.5) |
71.3 (4.1) |
68 (2.4) |
68.4 (3.5) |
67.7 (2.6) |
|
BMI (kg/m2) |
26.04 (1.02) |
33.38 (1.85) |
26.78 (0.78) |
34.45 (1.10) |
26.24 (0.68) |
35.44 (1.31) |
|
|
||||||
|
Values are expressed as mean (standard error of the mean). BMI, body mass index; F, female; M, male. |
||||||
|
Pallu et al. Arthritis Research & Therapy 2010 12:R112 doi:10.1186/ar3048 |
||||||
